Mosaic ImmunoEngineering, Inc.
CPMV
$0.538
$0.23879.33%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.75% | -8.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.38% | -19.42% | |||
| Operating Income | -16.38% | 19.42% | |||
| Income Before Tax | -20.39% | 19.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.50% | 18.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.50% | 18.05% | |||
| EBIT | -16.38% | 19.42% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -18.96% | 18.22% | |||
| Normalized Basic EPS | -20.77% | 19.25% | |||
| EPS Diluted | -18.96% | 29.67% | |||
| Normalized Diluted EPS | -20.77% | 19.25% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||